Published Date:2024-01-29 Original Link:https://www.onenessbio.com/en/news_detail262_5.htm No 1 Date of announcement 2024/01/29 Time of announcement 22:06:46 Subject Fespixon is included in the 2024 TSOC/TSPS Joint Consensus and has been published by a renowned SCI journal, Acta Cardiologica Sinica. To which item it meets paragraph 53 Date of events 2024/01/29 Statement Date of occurrence of the event: 2024/01/29...Read More
Published Date:2024-01-18 Original Link:https://www.onenessbio.com/en/news_detail261_5.htm No 1 Date of announcement 2024/01/18 Time of announcement 17:34:50 Subject Oneness was notified today that Bonvadis, the wound care topical cream has obtained import license in Thailand. To which item it meets paragraph 10 Date of events 2024/01/18 Statement Product:Bonvadis topical cream for wound care Mass production date: NA Effect...Read More
Published Date:2024-01-05 Original Link:https://www.onenessbio.com/en/news_detail260_5.htm No 1 Date of announcement 2024/01/05 Time of announcement 17:06:26 Subject Oneness Biotech to Present at the 42nd Annual J.P. Morgan Healthcare Conference To which item it meets paragraph 12 Date of events 2024/01/10 Statement Date of institutional investor conference:2024/01/10 Time of institutional investor conference:06:30 (CST) Location of institutional investor conference:San...Read More
Published Date:2023-12-25 Original Link:https://www.onenessbio.com/en/news_detail259_1.htm No 1 Date of announcement 2023/12/25 Time of announcement 18:06:04 Subject Oneness has submitted medical device registration application of Bonvadis for wound care to the Saudi Food and Drug Authority (SFDA) in Kingdom of Saudi Arabia. To which item it meets paragraph 10 Date of events 2023/12/25 Statement Product:Bonvadis for wound...Read More
Published Date:2023-12-19 Original Link:https://www.onenessbio.com/en/news_detail257_1.htm No 1 Date of announcement 2023/12/19 Time of announcement 16:27:57 Subject Oneness announces the information about the investor’s conference of 2023 Q4. To which item it meets paragraph 12 Date of events 2023/12/26 Statement Date of institutional investor conference: 2023/12/26 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor...Read More
Published Date:2023-12-13 Original Link:https://www.onenessbio.com/en/news_detail256_1.htm No 1 Date of announcement 2023/12/13 Time of announcement 17:21:59 Subject Oneness Biotech Co., Ltd. receives an Indian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2023/12/13 Statement Date of occurrence of the event:2023/12/13 Company...Read More
Published Date:2023-12-07 Original Link:https://www.onenessbio.com/en/news_detail255_1.htm No 1 Date of announcement 2023/12/07 Time of announcement 17:11:46 Subject Oneness Biotech Co., Ltd. receives a Brazilian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets paragraph 53 Date of events 2023/12/07 Statement Date of occurrence of the event:2023/12/07 Company...Read More
Published Date:2023-12-05 Original Link:https://www.onenessbio.com/en/news_detail254_1.htm No 1 Date of announcement 2023/12/05 Time of announcement 18:27:10 Subject A U.S. patent titled “METHODS FOR PREPARATION OF PLECTRANTHUS AMBOINICUS EXTRACTS” has been granted. To which item it meets paragraph 53 Date of events 2023/12/05 Statement Date of occurrence of the event:2023/12/05 Company name:ONENESS BIOTECH CO., LTD. Relationship to the...Read More
Published Date:2023-12-04 Original Link:https://www.onenessbio.com/en/news_detail253_1.htm No 1 Date of announcement 2023/12/04 Time of announcement 18:55:48 Subject Oneness Biotech Co., Ltd. receives a Japanese patent titled “TREATING IGE-MEDIATED ALLERGIC DISEASES” on FB825. To which item it meets paragraph 53 Date of events 2023/12/04 Statement Date of occurrence of the event:2023/12/04 Company name:ONENESS BIOTECH CO., LTD. Relationship to...Read More
